Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity

S Baghdiguian, P Nickel, J Fantini - Cancer letters, 1991 - Elsevier
screening of new therapeutic agents, we have developed a two-step protocol for testing
suramin derivatives … as suramin to induce the differentiation of the human colic adenocarcinema …

100 years of suramin

N Wiedemar, DA Hauser, P Mäser - Antimicrobial agents and …, 2020 - Am Soc Microbiol
… Here, we provide an overview of the many different … , more specific, and less toxic molecules
can be identified for the … least) two pathways for receptor-mediated endocytosis of suramin in …

A second WNT for old drugs: drug repositioning against WNT-dependent cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - mdpi.com
… to this list inhibition by suramin of at least two targets within the … administration of suramin
results in multiple toxicities and the … of human colon cancer and lung cancer cells both in vitro …

Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells

S Baghdiguian, JA Boudier, JL Boudier, J Fantini - Cancer letters, 1996 - Elsevier
… of suramin and serum albumin in human colon cancer cells (HT-29-D4) upon suramin
treatment. … were performed on HT-29-D4 cells grown in serum free medium containing both [ 3 H]…

Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme

F Naghibalhossaini, P Ebadi - Cancer letters, 2006 - Elsevier
… of suramin has been also reported on the human stomach … to suramin (2 h) could augment
CEA secretion from this cell. … Cell toxicity was observed with concentrations above 4 μg/ml of …

Suramin inhibits glioma cell proliferationin vitro and in the brain

S Takano, S Gately, H Engelhard… - Journal of neuro …, 1994 - Springer
… Furthermore, the development of less toxic analogs of suramin that … : Double screening of
suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic

Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics

A Kirtonia, K Gala, SG Fernandes, G Pandya… - Seminars in cancer …, 2021 - Elsevier
… In the last two decades, appreciable progress has been … , chemotherapeutic agents have
significant toxicity and badly … In a cohort study with 15,052 colorectal cancer patients, that …

Fibroblast growth factors and their inhibitors

F Manetti, F Corelli, M Botta - Current pharmaceutical design, 2000 - ingentaconnect.com
… adult brain and testis, and in human colon carcinoma cell lines [58]. Recently, suramin (1) has
… an anabolic effect in bone, suggesting this protein as a potentially useful therapeutic agent

Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme

M Nikanjam, AR Gibbs, CA Hunt, TF Budinger… - Journal of Controlled …, 2007 - Elsevier
… target for the delivery of therapeutic agents. A synthetic nano-… with suramin compared to the
control without suramin (12% … and receptor activity has been observed in colon cancer [53], …

Tissue protective and anti-fibrotic actions of suramin: new uses of an old drug

N Liu, S Zhuang - Current clinical pharmacology, 2011 - ingentaconnect.com
… , colorectal cancer, colon cancer, pancreatic cancer and high… that suramin induces activation
of Src and AKT, two important … suramin has significant toxicity when it is used as a cytotoxic …